Physician profile
Alkesh Amin
NPI 1114242930
$1,893.34
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $522 · 2020: $365 · 2021: $448 · 2022: $204 · 2023: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $421.76 | 2019-2022 | |
| Cook Medical LLC | $299.51 | 2019-2023 | Hemospray |
| Terumo Medical Corporation | $178.91 | 2019-2021 | |
| Argon Medical Devices, INC. | $144.73 | 2020 | |
| Medtronic, INC. | $131.59 | 2021 | |
| Stryker Corporation | $124.55 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.55 | 2023 | |
| Medtronic USA, INC. | $123.01 | 2020 | |
| Bard Peripheral Vascular, INC. | $109.89 | 2019 | |
| Penumbra, INC. | $98.65 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $87.27 | 2021 | |
| B. Braun Interventional Systems INC. | $21.50 | 2021 | |
| Teleflex LLC | $15.82 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $11.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alkesh Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.